[Clinical and practical aspects of multidrug-resistant pathogens].

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Urology

Background:

• Multidrug-resistant (MDR) pathogens arise from complex risk factors and antibiotic misuse.
• MDR Gram-negative bacteria are a significant concern, particularly in vulnerable patient groups.
• Key risk factors include prior antibiotic exposure, recurrent hospitalizations, and invasive devices.

Purpose of the Study:

• To emphasize the critical distinction between asymptomatic bacteriuria and clinical urinary tract infections (UTIs).
• To guide appropriate antimicrobial therapy selection based on disease severity and infection site.
• To outline diagnostic and therapeutic strategies for MDR pathogens in urology.

Main Methods:

• Clinical management principles for MDR pathogens.
• Diagnostic work-up for risk stratification and treatment planning in urology.
• Therapeutic approach involving empirical treatment, de-escalation, and guideline-based risk assessment.

Main Results:

• Antimicrobial therapy is indicated solely for clinically manifested infections, not asymptomatic bacteriuria.
• Treatment decisions for MDR infections must prioritize disease severity and the infection focus.
• Diagnostic work-up in urology aids in stratifying patient risk and planning effective treatments.

Conclusions:

• Strict differentiation between bacteriuria and UTI is essential for judicious antibiotic use.
• Therapeutic strategies for MDR pathogens should follow a de-escalation principle.
• Perioperative management of MDR pathogen colonization requires careful, guideline-adherent risk assessment.